Aventis Gains Expedited Review, March Panel For HIV-Indicated Dermal Filler

Expedited review of Aventis/Dermik Laboratories' Sculptra dermal filler to treat facial lipoatrophy in HIV-positive patients will precede a planned U.S. wrinkle indication, the firm says